Lifevantage Corporation (LFVN) Shares are Up 1.29%

Lifevantage Corporation (LFVN) has been under a strong bear grip, hence the stock is down -10.72% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 1.33% in the past 1 week. The stock has risen by 1.29% in the past week indicating that the buyers are active at lower levels, but the stock is down -10.38% in the past 4 weeks.

Lifevantage Corporation is up 7.34% in the last 3-month period. Year-to-Date the stock performance stands at 39.71%. The stock has recorded a 20-day Moving Average of 3.11% and the 50-Day Moving Average is 4.81%.


Lifevantage Corporation (NASDAQ:LFVN): The stock opened at $13.72 on Friday but the bulls could not build on the opening and the stock topped out at $13.77 for the day. The stock traded down to $13.24 during the day, due to lack of any buying support eventually closed down at $13.30 with a loss of -3.34% for the day. The stock had closed at $13.76 on the previous day. The total traded volume was 53,432 shares.

LifeVantage Corporation is engaged in the identification, research, development and distribution of nutraceutical dietary supplements and skin care products. The Companys products include Protandim, a dietary supplement that reduces the age-dependent growth in markers of oxidative stress; LifeVantage TrueScience, a line of anti-aging skin care products, which include TrueScience Ultra Gentle Facial Cleanser, TrueScience Perfecting Lotion, TrueScience Eye Corrector Serum and TrueScience Anti-Aging Cream; Canine Health, a pet supplement formulated to combat oxidative stress in dogs, and Axio, an energy drink mix formulated to promote alertness and support mental performance. The Company sells its products to an international network of independent distributors in the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico and Thailand.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.